Cargando…
The dichotomous and incomplete adaptive immunity in COVID-19 patients with different disease severity
The adaptive immunity that protects patients from coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is not well characterized. In particular, the asymptomatic patients have been found to induce weak and transient SARS-CoV-2 antibody response...
Autores principales: | Gao, Leiqiong, Zhou, Jing, Yang, Sen, Wang, Lisha, Chen, Xiangyu, Yang, Yang, Li, Ren, Pan, Zhiwei, Zhao, Jing, Li, Zhirong, Huang, Qizhao, Tang, Jianfang, Hu, Li, Liu, Pinghuang, Zhang, Guozhong, Chen, Yaokai, Ye, Lilin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7938043/ https://www.ncbi.nlm.nih.gov/pubmed/33686064 http://dx.doi.org/10.1038/s41392-021-00525-3 |
Ejemplares similares
-
Disease severity dictates SARS-CoV-2-specific neutralizing antibody responses in COVID-19
por: Chen, Xiangyu, et al.
Publicado: (2020) -
Human monoclonal antibodies block the binding of SARS-CoV-2 spike protein to angiotensin converting enzyme 2 receptor
por: Chen, Xiangyu, et al.
Publicado: (2020) -
Nasal Spray of Neutralizing Monoclonal Antibody 35B5 Confers Potential Prophylaxis Against Severe Acute Respiratory Syndrome Coronavirus 2 Variants of Concern: A Small-Scale Clinical Trial
por: Lin, Yao, et al.
Publicado: (2022) -
Sensitivity of SARS-CoV-2 Variants to Neutralization by Convalescent Sera and a VH3-30 Monoclonal Antibody
por: Yue, Shuai, et al.
Publicado: (2021) -
Differential expression of inhibitory receptor NKG2A distinguishes disease‐specific exhausted CD8(+) T cells
por: Chen, Xiangyu, et al.
Publicado: (2022)